Malignant Extrahepatic Bile Duct Neoplasm

Malignant Extrahepatic Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05009953	Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer	terminated	Phase 2	17	CSPC Ouyi Pharmaceutical Co., Ltd.INDUSTRY	1	Jul 11, 2024	clinicaltrials
NCT00478140	Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery	terminated	Phase 2	4	National Cancer Institute (NCI)NIH	1	Aug 20, 2019	clinicaltrials